Related Experiment Video

Updated: Sep 1, 2025

Production of Human CRISPR-Engineered CAR-T Cells
06:33

Production of Human CRISPR-Engineered CAR-T Cells

Published on: March 15, 2021

13.3K

i-CRISPR: a personalized cancer therapy strategy through cutting cancer-specific mutations

Junfeng Jiang1,2, Yuanyuan Chen3, Li Zhang4

  • 1Histology and Embryology Department, Naval Medical University, 800, Xiangyin Road, 200433, Shanghai, People's Republic of China.

Molecular Cancer
|August 16, 2022
PubMed

Insights

This study introduces i-CRISPR, a precise cancer therapy combining DNA damage repair inhibitors with CRISPR-induced DNA breaks. This strategy effectively targets cancer cells, offering a novel approach for personalized cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Editing

Background:

  • Developing targeted cancer therapies that minimize harm to healthy tissues is a critical clinical challenge.
  • Current treatments often lack specificity, leading to significant side effects.

Discussion:

  • The study presents "i-CRISPR," a novel precision cancer therapy strategy.
  • This approach combines DNA damage repair inhibitors (i) with CRISPR-Cas9 technology to induce targeted DNA double-strand breaks specifically in cancer cells.
  • This targeted DNA damage aims to trigger cancer cell-specific death pathways.

Key Insights:

  • In vitro and in vivo experiments validated the efficacy of i-CRISPR across multiple cancer models.
  • The study elucidated the underlying mechanisms of cancer cell death induced by this strategy.
  • i-CRISPR demonstrated significant potential in eradicating cancer cells while sparing normal cells.

Outlook:

  • This precise, personalized strategy offers a new conceptual framework for advanced cancer treatment.
  • Further research may explore the clinical translation and broader applications of i-CRISPR.
  • The findings pave the way for developing more effective and less toxic cancer therapies.
Keywords:
CRISPR-Cas9Cancer mutation sequencingDNA damage repairGene editing

More Related Videos

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells07:56

Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells

Published on: July 22, 2019

11.4K
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

419

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.8K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
181
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
646